King Hussein Institute for Biotechnology and Cancer (KHIBC) is a not-for-profit nongovernmental organization established in concordance with His Majesty King Abdullah II's vision of transforming Jordan into a regional and international center for healthcare and research. KHIBC aims to provide state-of-the-art care for the purpose of eliminating suffering and death from cancer through education, awareness, prevention, diagnosis and treatment. Furthermore, the Institute aims to advance life sciences and biotechnology and their contribution to medicine in the world through innovative research and scientific discoveries. The Office of Science, Health and Research Policy at KHIBC represents the “think tank” of KHIBC, it aims to provide Jordan and the region with a prominent source of thought leadership on emerging issues in health policy, health economics, medical anthropology and bioethics. The Center for Health Policy under the Office of Science, Health and Research Policy at King Hussein Institute for Biotechnology and Cancer assesses Jordan's governance on research and development in the field of biosciences and biotechnology. It is also currently working with key stakeholders and international organizations on developing the National Medical Biotechnology Strategy for Jordan. The Office of Science and Technology Development at KHIBC represents the Business Development arm of the Institute. The Office serves as a catalyst for research and development through collaborations with both internal and external partners to create access to the most innovative science and technologies. In fact, the Office's mission statement is to enable KHIBC to achieve excellence and fulfill its needs to conduct innovative “bench-to-bedside” research.